Stock MEDICAPQ6 MEDI-CAPS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medi-Caps Limited

Equities

MEDICAPQ6

INE442D01010

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 02:15:39 2024-06-27 EDT 		5-day change 1st Jan Change
49.31 INR -1.75% Intraday chart for Medi-Caps Limited -6.66% +0.55%
05-28 Medi-Caps Limited Announces Retirement of Mr. Pramod Fatehpuria as Independent Director CI
05-23 Medi-Caps Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 287.4 206.4 101.9 503.2 619.1 435.6
Enterprise Value (EV) 1 174.3 59.76 -95.18 172.1 252 73.15
P/E ratio 25.1 x 3.83 x -1.74 x 4.52 x 6.14 x 24.8 x
Yield - - - - - -
Capitalization / Revenue 0.57 x 0.4 x 0.23 x 0.86 x 0.89 x 0.88 x
EV / Revenue 0.35 x 0.12 x -0.21 x 0.29 x 0.36 x 0.15 x
EV / EBITDA 8.43 x 1.28 x 1.76 x 1.41 x 2.49 x 1.43 x
EV / FCF 7.48 x 3.83 x -2.33 x 2.97 x -11.2 x 10.4 x
FCF Yield 13.4% 26.1% -42.9% 33.7% -8.95% 9.62%
Price to Book 0.32 x 0.22 x 0.11 x 0.48 x 0.53 x 0.37 x
Nbr of stocks (in thousands) 12,470 12,470 12,470 12,470 12,470 12,470
Reference price 2 23.05 16.55 8.170 40.35 49.65 34.93
Announcement Date 18-09-18 19-08-28 20-09-06 21-09-01 22-09-03 23-09-04
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 501.6 517.8 446 583.8 698.7 493.7
EBITDA 1 20.67 46.52 -54.03 121.7 101.1 51.3
EBIT 1 2.749 28.31 -71.12 103.2 82.04 33.19
Operating Margin 0.55% 5.47% -15.95% 17.67% 11.74% 6.72%
Earnings before Tax (EBT) 1 13.48 55.03 -58.44 112.4 100.6 49.21
Net income 1 11.48 53.87 -58.52 111.3 100.8 17.56
Net margin 2.29% 10.4% -13.12% 19.06% 14.43% 3.56%
EPS 2 0.9200 4.320 -4.693 8.925 8.080 1.408
Free Cash Flow 1 23.29 15.6 40.85 57.97 -22.55 7.04
FCF margin 4.64% 3.01% 9.16% 9.93% -3.23% 1.43%
FCF Conversion (EBITDA) 112.67% 33.54% - 47.64% - 13.72%
FCF Conversion (Net income) 202.98% 28.97% - 52.09% - 40.1%
Dividend per Share - - - - - -
Announcement Date 18-09-18 19-08-28 20-09-06 21-09-01 22-09-03 23-09-04
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 113 147 197 331 367 362
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 23.3 15.6 40.9 58 -22.5 7.04
ROE (net income / shareholders' equity) 1.28% 5.8% -6.27% 11.5% 9.09% 1.59%
ROA (Net income/ Total Assets) 0.17% 1.71% -4.41% 6.14% 4.18% 1.62%
Assets 1 6,626 3,159 1,328 1,813 2,410 1,085
Book Value Per Share 2 72.30 76.70 72.90 84.00 93.20 95.10
Cash Flow per Share 2 1.860 1.990 1.000 0.3200 0.1800 0.8900
Capex 1 6.87 5.87 12.5 22.6 27.9 11.6
Capex / Sales 1.37% 1.13% 2.81% 3.87% 4% 2.36%
Announcement Date 18-09-18 19-08-28 20-09-06 21-09-01 22-09-03 23-09-04
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
MEDI-CAPS LIMITED Stock Medi-Caps Limited
+0.55% 7.49M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+54.61% 811B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+44.25% 640B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.62% 333B
ABBVIE INC. Stock AbbVie Inc.
+10.44% 302B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.45% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+2.09% 225B
NOVARTIS AG Stock Novartis AG
+13.03% 218B
AMGEN INC. Stock Amgen Inc.
+8.61% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MEDICAPQ6 Stock
  4. Financials Medi-Caps Limited